Identification of mutations in SLC4A1, GP1BA and HFE in a family with venous thrombosis of unknown cause by next‑generation sequencing

Chang,Wei‑An; Sheu,Chau‑Chyun; Liu,Kuan‑Ting; Shen,Jheng‑Heng; Yen,Meng‑Chi; Kuo,Po‑Lin

doi:10.3892/etm.2018.6693

Identification of mutations in SLC4A1, GP1BA and HFE in a family with venous thrombosis of unknown cause by next‑generation sequencing

Authors:
- Wei‑An Chang
- Chau‑Chyun Sheu
- Kuan‑Ting Liu
- Jheng‑Heng Shen
- Meng‑Chi Yen
- Po‑Lin Kuo
View Affiliations

Affiliations: Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan, R.O.C.
Published online on: September 4, 2018 https://doi.org/10.3892/etm.2018.6693
Pages: 4172-4180

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Various risk factors, including high age, female gender, obesity and certain genetic defects have been linked to venous thrombosis. A Taiwanese family with venous thrombosis of unknown cause were enrolled in the present study. In this pedigree, two women without any specific underlying diseases suffered from venous thrombotic events at the same age. No specific risk factors or coagulation abnormalities were identified. The main proband's younger brother also had intestinal arterial thrombosis at 54 years of age. Therefore, it was hypothesized that familial genetic defects may be the cause of venous thrombosis within this family. Blood samples collected from certain members of this pedigree were subjected to whole‑exome sequencing, and three genetic variants were identified, including a missense variant of solute carrier family 4 member 1 (SLC4A1) (c.388G>A), a deletion on glycoprotein Ib platelet α subunit (GP1BA) (c.1322_1344del23) and an insertion in the splice site of homeostatic iron regulator (HFE). To date, none of these three genetic variants have been reported to be associated with venous thrombosis, to the best of our knowledge. The present study suggests that these genetic variants of SLC4A1, GP1BA and HFE may be associated with venous thrombosis in an Asian pedigree.

View Figures

View References

1	Rosendaal FR and Reitsma PH: Genetics of venous thrombosis. J Thromb Haemost. 7 Suppl 1:S301–S304. 2009. View Article : Google Scholar
2	Miyata T, Maruyama K, Banno F and Neki R: Thrombophilia in East Asian countries: Are there any genetic differences in these countries? Thromb J. 14 Suppl 1:S252016. View Article : Google Scholar
3	Makris M, Rosendaal FR and Preston FE: Familial thrombophilia: Genetic risk factors and management. J Intern Med Suppl. 740:9–15. 1997. View Article : Google Scholar : PubMed/NCBI
4	Lotta LA, Wang M, Yu J, Martinelli I, Yu F, Passamonti SM, Consonni D, Pappalardo E, Menegatti M, Scherer SE, et al: Identification of genetic risk variants for deep vein thrombosis by multiplexed next-generation sequencing of 186 hemostatic/pro-inflammatory genes. BMC Med Genomics. 5:72012. View Article : Google Scholar : PubMed/NCBI
5	Lotta LA, Tuana G, Yu J, Martinelli I, Wang M, Yu F, Passamonti SM, Pappalardo E, Valsecchi C, Scherer SE, et al: Next-generation sequencing study finds an excess of rare, coding single-nucleotide variants of ADAMTS13 in patients with deep vein thrombosis. J Thromb Haemost. 11:1228–1239. 2013. View Article : Google Scholar : PubMed/NCBI
6	Morange PE, Suchon P and Trégouët DA: Genetics of venous thrombosis: Update in 2015. Thromb Haemost. 114:910–919. 2015. View Article : Google Scholar : PubMed/NCBI
7	Sulger E and Gonzalez L: Mesenteric venous thrombosisStatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2017, https://www.ncbi.nlm.nih.gov/books/NBK459184/January 15–2018
8	Singh M, Long B and Koyfman A: Mesenteric ischemia: A deadly miss. Emerg Med Clin North Am. 35:879–888. 2017. View Article : Google Scholar : PubMed/NCBI
9	Bolger AM, Lohse M and Usadel B: Trimmomatic: A flexible trimmer for Illumina sequence data. Bioinformatics. 30:2114–2120. 2014. View Article : Google Scholar : PubMed/NCBI
10	Li H and Durbin R: Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 25:1754–1760. 2009. View Article : Google Scholar : PubMed/NCBI
11	DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, Hartl C, Philippakis AA, del Angel G, Rivas MA, Hanna M, et al: A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet. 43:491–498. 2011. View Article : Google Scholar : PubMed/NCBI
12	McLaren W, Gil L, Hunt SE, Riat HS, Ritchie GR, Thormann A, Flicek P and Cunningham F: The ensembl variant effect predictor. Genome Biol. 17:1222016. View Article : Google Scholar : PubMed/NCBI
13	Landrum MJ, Lee JM, Benson M, Brown G, Chao C, Chitipiralla S, Gu B, Hart J, Hoffman D, Hoover J, et al: ClinVar: Public archive of interpretations of clinically relevant variants. Nucleic Acids Res. 44:D862–D868. 2016. View Article : Google Scholar : PubMed/NCBI
14	Chen CH, Yang JH, Chiang CWK, Hsiung CN, Wu PE, Chang LC, Chu HW, Chang J, Song IW, Yang SL, et al: Population structure of Han Chinese in the modern Taiwanese population based on 10,000 participants in the Taiwan Biobank project. Hum Mol Genet. 25:5321–5331. 2016.PubMed/NCBI
15	da Huang W, Sherman BT and Lempicki RA: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
16	da Huang W, Sherman BT and Lempicki RA: Bioinformatics enrichment tools: Paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 37:1–13. 2009. View Article : Google Scholar : PubMed/NCBI
17	Kunicki TJ, Williams SA and Nugent DJ: Genetic variants that affect platelet function. Curr Opin Hematol. 19:371–379. 2012. View Article : Google Scholar : PubMed/NCBI
18	Korte W, Poon MC, Iorio A and Makris M: Thrombosis in inherited fibrinogen disorders. Transfus Med Hemother. 44:70–76. 2017. View Article : Google Scholar : PubMed/NCBI
19	Liu Y, Yang J and Chen LM: Structure and function of SLC4 family [formula: See text] transporters. Front Physiol. 6:3552015. View Article : Google Scholar : PubMed/NCBI
20	Perkins LA, Jones SF and Bhargava RS: Dural venous thrombosis following splenectomy in a patient with hereditary spherocytosis. South Med J. 102:542–545. 2009. View Article : Google Scholar : PubMed/NCBI
21	Agarwal SK, Binbrek AS, Thompson JA and Siddiqui SA: Massive pulmonary embolism and acute limb ischaemia in a patient of hereditary spherocytosis and patent foramen ovale. Heart Lung Circ. 19:742–744. 2010. View Article : Google Scholar : PubMed/NCBI
22	Ozaki Y, Asazuma N, Suzuki-Inoue K and Berndt MC: Platelet GPIb-IX-V-dependent signaling. J Thromb Haemost. 3:1745–1751. 2005. View Article : Google Scholar : PubMed/NCBI
23	Watkins NA, Gusnanto A, de Bono B, De S, Miranda-Saavedra D, Hardie DL, Angenent WG, Attwood AP, Ellis PD, Erber W, et al: A HaemAtlas: Characterizing gene expression in differentiated human blood cells. Blood. 113:e1–e9. 2009. View Article : Google Scholar : PubMed/NCBI
24	Enayat S, Ravanbod S, Rassoulzadegan M, Jazebi M, Tarighat S, Ala F, Emsley J and Othman M: A novel D235Y mutation in the GP1BA gene enhances platelet interaction with von Willebrand factor in an Iranian family with platelet-type von Willebrand disease. Thromb Haemost. 108:946–954. 2012. View Article : Google Scholar : PubMed/NCBI
25	Lavenu-Bombled C, Guitton C, Dupuis A, Baas MJ, Desconclois C, Dreyfus M, Li R, Caron C, Gachet C, Fressinaud E and Lanza F: A novel platelet-type von Willebrand disease mutation (GP1BA p. Met255Ile) associated with type 2B ‘Malmö/New York’ von Willebrand disease. Thromb Haemost. 116:1070–1078. 2016. View Article : Google Scholar : PubMed/NCBI
26	Woods AI, Sanchez-Luceros A, Bermejo E, Paiva J, Alberto MF, Grosso SH, Kempfer AC and Lazzari MA: Identification of p.W246L as a novel mutation in the GP1BA gene responsible for platelet-type von Willebrand disease. Semin Thromb Hemost. 40:151–160. 2014. View Article : Google Scholar : PubMed/NCBI
27	Ali S, Ghosh K and Shetty S: Novel genetic abnormalities in bernard-soulier syndrome in india. Ann Hematol. 93:381–384. 2014. View Article : Google Scholar : PubMed/NCBI
28	Shlebak A, Poles A, Manning R, Almuhareb S, De La Funte J, Mitchell M and Lucas G: A novel homozygous c.800C>G substitution in GP1BA exon 2 in a kuwaiti family with bernard-soulier syndrome. Acta Haematol. 134:193–198. 2015. View Article : Google Scholar : PubMed/NCBI
29	Afrasiabi A, Lecchi A, Artoni A, Karimi M, Ashouri E, Peyvandi F and Mannucci PM: Genetic characterization of patients with bernard-soulier syndrome and their relatives from Southern Iran. Platelets. 18:409–413. 2007. View Article : Google Scholar : PubMed/NCBI
30	Ali S, Shetty S and Ghosh K: A novel mutation in GP1BA gene leads to mono-allelic bernard soulier syndrome form of macrothrombocytopenia. Blood Coagul Fibrinolysis. 28:94–95. 2017. View Article : Google Scholar : PubMed/NCBI
31	Biguzzi E, Franchi F, Acaia B, Ossola W, Nava U, Paraboschi EM, Asselta R and Peyvandi F: Genetic background and risk of postpartum haemorrhage: Results from an Italian cohort of 3219 women. Haemophilia. 20:e377–e383. 2014. View Article : Google Scholar : PubMed/NCBI
32	Valenti L and Pelusi S: HFE mutations and iron in hemodialysis patients. Hemodial Int. 21 Suppl 1:S47–S57. 2017. View Article : Google Scholar : PubMed/NCBI
33	Brown K, Luddington R, Taylor SA, Lillicrap DP and Baglin TP: Risk of venous thromboembolism associated with the common hereditary haemochromatosis Hfe gene (C282Y) mutation. Br J Haematol. 105:95–97. 1999. View Article : Google Scholar : PubMed/NCBI
34	Dionisio Tavares Niewiadonski V, Dos Santos Bianchi JV, de Almeida-Neto C, Gaburo N Jr and Sabino EC: Evaluation of a high throughput method for the detection of mutations associated with thrombosis and hereditary hemochromatosis in Brazilian blood donors. PLoS One. 10:e01254602015. View Article : Google Scholar : PubMed/NCBI
35	Ingelman-Sundberg M: Pharmacogenetics of cytochrome P450 and its applications in drug therapy: The past, present and future. Trends Pharmacol Sci. 25:193–200. 2004. View Article : Google Scholar : PubMed/NCBI
36	Wang B, Yang LP, Zhang XZ, Huang SQ, Bartlam M and Zhou SF: New insights into the structural characteristics and functional relevance of the human cytochrome P450 2D6 enzyme. Drug Metab Rev. 41:573–643. 2009. View Article : Google Scholar : PubMed/NCBI
37	Wang D, Poi MJ, Sun X, Gaedigk A, Leeder JS and Sadee W: Common CYP2D6 polymorphisms affecting alternative splicing and transcription: Long-range haplotypes with two regulatory variants modulate CYP2D6 activity. Hum Mol Genet. 23:268–278. 2014. View Article : Google Scholar : PubMed/NCBI
38	Sistonen J, Fuselli S, Levo A and Sajantila A: CYP2D6 genotyping by a multiplex primer extension reaction. Clin Chem. 51:1291–1295. 2005. View Article : Google Scholar : PubMed/NCBI
39	Goh LL, Lim CW, Sim WC, Toh LX and Leong KP: Analysis of genetic variation in CYP450 genes for clinical implementation. PLoS One. 12:e01692332017. View Article : Google Scholar : PubMed/NCBI